To investigate whether dWAT responses to EGFR inhibition, we established a rat rash model by repeated oral gavage of Afatinib (Afa), an EGFR inhibitor with a high occurrence of skin toxicity (Sequist et al., 2013). Here, EGFR is linked to Skin rash.